FDA corrects claims by Sprout Pharmaceuticals about its libido-boosting drug

The U.S. Food and Drug Administration has corrected claims by Raleigh-based Sprout Pharmaceuticals that its drug, the female libido pill Addyi, no longer requires health care practitioners or pharmacies to be certified by the FDA to prescribe or dispense the pill.